1. Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment
    Ewelina Dratkiewicz et al, 2019, International Journal of Molecular Sciences CrossRef
  2. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
    Louise Marchandet et al, 2021, Cancers CrossRef
  3. LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion
    Rong Li et al, 2022, Frontiers in Oncology CrossRef
  4. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein
    Lu Ding et al, 2021, Aging CrossRef
  5. Targeting the Hippo Pathway in Prostate Cancer: What’s New?
    Kelly Coffey, 2021, Cancers CrossRef
  6. Screening and Interaction Analysis of Key Genes in miR-542-3p Over- Expressed Osteosarcoma Cells by Bioinformatics
    Zhongqiu Li et al, 2020, Combinatorial Chemistry & High Throughput Screening CrossRef
  7. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition
    Jingjing Sha et al, 2021, Biomolecules CrossRef
  8. Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance
    Martina Radić et al, 2022, International Journal of Molecular Sciences CrossRef
  9. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
    Ingrid Lilienthal et al, 2020, International Journal of Molecular Sciences CrossRef